Blincyto 35 mcg lyophilized powder for injection Images
Generic Name: blinatumomab
This medication has been identified as Blincyto 35 mcg lyophilized powder for injection. It is supplied by Amgen Inc.
Blincyto is used in the treatment of Acute Lymphoblastic Leukemia and belongs to the drug class bispecific T-cell engagers (BiTE). Risk cannot be ruled out during pregnancy. Blincyto 35 mcg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Blincyto
- Generic Name
- blinatumomab
- Strength
- 35 mcg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Bispecific T-cell engagers (BiTE)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Amgen Inc.
- National Drug Code (NDC)
- 55513-0160
See also:
Sprycel
Sprycel is used to treat chronic myeloid leukemia and acute lymphoblastic leukemia. Learn about ...
Gleevec
Gleevec is targeted cancer therapy for specific types of leukemia (blood cancer), bone marrow ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Otrexup
Otrexup is used for polyarticular juvenile idiopathic arthritis, psoriasis, rheumatoid arthritis
Trexall
Trexall is used for acute lymphoblastic leukemia, acute lymphocytic leukemia, breast cancer ...
Rasuvo
Rasuvo is used for polyarticular juvenile idiopathic arthritis, psoriasis, rheumatoid arthritis
Iclusig
Iclusig (ponatinib) used to treat a type of blood cancer called chronic myeloid leukemia (CML), or ...
Revuforj
Revuforj is used to treat acute leukemia with a lysine methyltransferase 2A gene translocation ...
More about Blincyto (blinatumomab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: bispecific T-cell engagers (BiTE)
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.